Home | Business News | Browse by Publication | B | Biotech Week

Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit Against Advanta Corp.

Publication: Biotech Week
Publication Date: 28-OCT-09 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
Coughlin Stoia Geller Rudman & Robbins LLP ("Coughlin Stoia") (http://www.csgrr.com/cases/advanta/) announced that a class action has been commenced on behalf of an institutional investor in the United States District Court for the Eastern District of Pennsylvania on behalf of purchasers of Advanta Corp. ("Advanta") (NASDAQ:ADVNA) (NASDAQ:ADVNB) Class A and/or Class B common stock during the period between October 31, 2006 and November 27, 2007 (the "Class Period") (see also Coughlin Stoia Geller Rudman & Robbins LLP).

If you wish to serve as lead plaintiff, you must move the Court no later than 60 days from today. If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff's counsel, Darren Robbins of Coughlin Stoia at 800-449-4900 or 619-231-1058,...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.